 SOMERSET, N.J.--BUSINESS WIRE--Catalent, Inc. Catalent NYSE: CTLT, the leading global provider of development sciences and manufacturing platforms for medicines, including biotherapeutics; cell and gene therapies; and consumer health products, today announced that its wholly owned subsidiary, Catalent Pharma Solutions, Inc. the Operating Subsidiary, priced a private offering the Private Offering of 650 million in aggregate principal amount of 3.500 senior unsecured notes due 2 